Puma Biotechnology Inc

NAS:PBYI (USA)  
$ 5.31 -0.28 (-5.02%) 11:08 PM EST
11.78
P/B:
4.73
Market Cap:
$ 255.98M
Enterprise V:
$ 285.03M
Volume:
265.81K
Avg Vol (2M):
710.08K
Volume:
265.81K
Avg Vol (2M):
710.08K

Business Description

Description
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
Name Current Vs Industry Vs History
Cash-To-Debt 0.86
Equity-to-Asset 0.23
Debt-to-Equity 2.09
Debt-to-EBITDA 2.35
Interest Coverage 2.5
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -5.42
Distress
Grey
Safe
Beneish M-Score -2.49
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 48.18
9-Day RSI 48.33
14-Day RSI 48.25
6-1 Month Momentum % 149.06
12-1 Month Momentum % 168.29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.57
Quick Ratio 1.5
Cash Ratio 0.97
Days Inventory 33.55
Days Sales Outstanding 55.64
Days Payable 40.5

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.9
Shareholder Yield % 0.97

Financials (Next Earnings Date:2024-05-03 Est.)

PBYI's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PBYI

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Puma Biotechnology Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 235.637
EPS (TTM) ($) 0.45
Beta 1.47
Volatility % 80.64
14-Day RSI 48.25
14-Day ATR ($) 0.480612
20-Day SMA ($) 5.29375
12-1 Month Momentum % 168.29
52-Week Range ($) 2.13 - 7.73
Shares Outstanding (Mil) 48.21

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Puma Biotechnology Inc Filings

Filing Date Document Date Form
No Filing Data

Puma Biotechnology Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Puma Biotechnology Inc Frequently Asked Questions

What is Puma Biotechnology Inc(PBYI)'s stock price today?
The current price of PBYI is $5.31. The 52 week high of PBYI is $7.73 and 52 week low is $2.13.
When is next earnings date of Puma Biotechnology Inc(PBYI)?
The next earnings date of Puma Biotechnology Inc(PBYI) is 2024-05-03 Est..
Does Puma Biotechnology Inc(PBYI) pay dividends? If so, how much?
Puma Biotechnology Inc(PBYI) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1